ストックスクリーナーアプリを入手
13.14
1.05%
-0.14
アフターアワーズ：
13.11
-0.03
-0.23%
Korro Bio Inc (KRRO) 最新ニュース
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Insider Selling: Korro Bio (NASDAQ:KRRO) Director Sells $29,916.28 in Stock - MarketBeat
Korro Bio director Jean Francois Formela sells $29,916 in shares - Investing.com
Korro Bio (KRRO) director-affiliated funds sell 2,143 shares under 10b5-1 plan - Stock Titan
Lynx1 Capital Management Lp Buys 5,222 Shares of Korro Bio (NASDAQ:KRRO) Stock - MarketBeat
Lynx1 Capital, Korro Bio 10% owner, buys $78,809 in stock - Investing.com
Lynx1 Capital, Korro Bio 10% owner, buys $78,809 in stock By Investing.com - Investing.com Canada
Korro Bio (KRRO) holder Lynx1 Capital reports 6,684-share indirect stock purchase - Stock Titan
HC Wainwright Has Strong Estimate for Korro Bio Q3 Earnings - MarketBeat
Korro Bio Inc (KRRO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
All You Need to Know About Korro Bio, Inc. (KRRO) Rating Upgrade to Buy - Yahoo Finance
A US$42m Market Cap Boost Pleasing ToKorro Bio Insiders - webull.com
Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP) and Korro Bio (KRRO) - theglobeandmail.com
Korro Bio (NASDAQ:KRRO) Releases Quarterly Earnings Results, Beats Expectations By $0.22 EPS - MarketBeat
Korro Bio (NASDAQ:KRRO) Upgraded at Wall Street Zen - MarketBeat
H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Cantor Fitzgerald Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $22 - Moomoo
Korro Bio, Inc. expected to post a loss of $1.43 a shareEarnings Preview - TradingView
William Blair Maintains Korro Bio(KRRO.US) With Buy Rating - Moomoo
Korro Bio Refines Capital Structure with Exchange Agreement - The Globe and Mail
Raymond James reiterates Korro Bio stock rating on hyperammonemia outlook - Investing.com South Africa
Chardan Capital Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Korro Bio earnings beat by $0.24, revenue topped estimates - Investing.com Canada
Korro Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Korro Bio Reports $18.9 Million Q2 Net Loss - Quiver Quantitative
Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Korro Bio Swaps 1.0M Shares for Pre-Funded Warrants to Venrock at $0.001 Exercise Price - TradingView
Korro Bio, Inc. Q2 2026: Revenue $0M, Net loss $(18.9)M, EPS $(1.07) — 10-Q Summary - TradingView
Korro Bio CEO Highlights Strategic Payoff, Advancing New Therapies - Intellectia AI
Korro Bio (KRRO) CEO sells 5,802 shares of stock to cover taxes - Stock Titan
Korro Bio (KRRO) Expected to Post Earnings on Tuesday - MarketBeat
Korro Bio (KRRO) Climbs 5.68% to $11.35 as RNA Editing Play Draws Fresh Buyer InterestFund Manager Survey - dars.gov.et
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ADAR1 Capital Management LLC Takes Position in Korro Bio, Inc. $KRRO - MarketBeat
Korro Bio Inc (KRRO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
KRRO|Korro Bio Inc|Price:10.370|Chg%:-0.080 - TradingKey
Korro Bio Inc (KRRO) Institutional Confidence - TradingKey
Korro Bio Inc (KRRO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Korro Bio, Inc. Revenue Breakdown – NASDAQ:KRRO - TradingView
Kalehua Capital Management LLC Acquires Shares of 109,376 Korro Bio, Inc. $KRRO - MarketBeat
Korro Bio Inc (KRRO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Korro Bio Inc (KRRO) Cash Flow - TradingKey
Korro Bio Inc (KRRO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Korro Bio Inc (KRRO) Balance Sheet - TradingKey
TradingKey - TradingKey
Korro Bio Inc (KRRO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
KRRO|Korro Bio Inc|Price:10.700|Chg%:+0.060 - TradingKey
KRRO|Korro Bio Inc|Price:10.640|Chg%:-0.890 - TradingKey
Affinity Asset Advisors LLC Buys New Shares in Korro Bio, Inc. $KRRO - MarketBeat
Korro Bio Inc (KRRO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Korro Bio Inc. (KRRO) Gains 4% as Biotech Momentum BuildsStrong Buy Stocks - dars.gov.et
Korro Bio, Inc. explores novel RNA editing approach for urea cycle disorder treatment - Traders Union
Form 4 Korro Bio Inc For: 17 July By Investing.com - Investing.com Nigeria
Korro Bio, Inc. (KRRO) awards 7,500 RSUs to Chief Operating Officer - Stock Titan
Korro Bio (KRRO) awards SVP 5,500 RSUs vesting through 2028 - Stock Titan
Korro Bio Inc. (KRRO) Slides 7% as Shares Test Key Support LevelsSupply Zone - dars.gov.et
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Price to earnings forward of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Price to sales forward of Korro Bio, Inc. – NASDAQ:KRRO - TradingView
Korro Bio, Inc. (KRRO) upgraded to buy: What does it mean for the stock? - MSN
Korro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
KRRO Q1 2026 Earnings: EPS Beat Driven by Cost Control and Clinical ProgressRevenue Report - dars.gov.et
Korro Bio: Why Director Sales Temper a 'Strong Buy' Consensus - Kavout | AI
Korro Bio director Formela sells $1.54m in shares - Investing.com
1.80%
1.77%
大文字化:
|
ボリューム (24 時間):